Blume-Jensen Peter disclosed grant / exercise in Acrivon Therapeutics, Inc. Common Stock
Blume-Jensen Peter grant / exercise $24.6K of disclosed value in Acrivon Therapeutics, Inc. Common Stock.
Signal
Insider Trade
Action
Grant / Exercise
Capital
$24.6K disclosed value
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from canonical action facts, not request-time scraping.